BH3-Interacting Domain Death Agonist (BID) Peptide

Este producto es parte de BID - BH3-interacting domain death agonist
Product Graph
175.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
BH3-Interacting Domain Death Agonist (BID) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269659
tested applications
P-ELISA

Description

BH3-Interacting Domain Death Agonist (BID) Peptide is a synthetic peptide. 

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
BH3-Interacting Domain Death Agonist (BID)
Host
Synthetic
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Observed MW
Sequence Fragment: C-Terminus: C-TYVRSLARNGMD
Size 1
100 µg
Form
Lyophilized Reconstitute in deionized water.
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
637
NCBI Accession
NP_932070.1, NP_001187.1, NP_932071.1
Alias
p22 BID,FP497
Background
Protein BID
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH0983

Human BID (BH3-interacting domain death agonist) ELISA Kit

Ver Producto
EH4219

Human Cleaved BID/TBID (Cleaved BH3-interacting domain death agonist) ELISA Kit

Ver Producto
FNab00892

BID antibody

The major proteolytic product p15 BID allows the release of cytochrome c(By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2.

Ver Producto